Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
35M
-
Number of holders
-
61
-
Total 13F shares, excl. options
-
21M
-
Shares change
-
+1.26M
-
Total reported value, excl. options
-
$123M
-
Value change
-
+$6.93M
-
Put/Call ratio
-
1.46
-
Number of buys
-
34
-
Number of sells
-
-45
-
Price
-
$5.86
Significant Holders of Apyx Medical Corp - Common Stock (APYX) as of Q2 2022
92 filings reported holding APYX - Apyx Medical Corp - Common Stock as of Q2 2022.
Apyx Medical Corp - Common Stock (APYX) has 61 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21M shares
of 35M outstanding shares and own 60.15% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (3.4M shares), COWEN AND COMPANY, LLC (2.82M shares), Archon Capital Management LLC (2.66M shares), VANGUARD GROUP INC (1.4M shares), PURA VIDA INVESTMENTS, LLC (1.32M shares), Kent Lake Capital LLC (1.2M shares), UBS Group AG (882K shares), HORIZON KINETICS ASSET MANAGEMENT LLC (615K shares), NEXT CENTURY GROWTH INVESTORS LLC (596K shares), and Invenire Partners, LP (578K shares).
This table shows the top 61 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.